SLU-PP-332

Why Researchers Choose SLU-PP-332

SLU-PP-332 is an estrogen-related receptor (ERR) pan-agonist studied as an exercise mimetic, a compound that reproduces metabolic adaptations of endurance training without physical activity. By activating ERR alpha, beta and gamma, it amplifies the PGC-1 alpha program that governs how muscle and other oxidative tissues generate energy. Research interest centres on:

• Mitochondrial biogenesis and oxidative-metabolism upregulation
• Exercise-mimetic modelling: increased running capacity and endurance in preclinical work
• Fat oxidation and energy-expenditure protocols that do not rely on appetite suppression
• Skeletal-muscle fibre-type and metabolic-flexibility research
• Comparison against incretin agonists for fat-mass reduction with preserved food intake

Because SLU-PP-332 acts upstream through nuclear-receptor transcription, it offers a mechanistically distinct route to fat metabolism and metabolic endurance compared with GLP-1 or GLP-1/GIP peptides.

ERR Signalling and Energy Expenditure

ERR receptors are orphan nuclear receptors that coordinate the transcription of genes for oxidative phosphorylation, mitochondrial assembly and fatty-acid catabolism. When SLU-PP-332 engages them:

1. The PGC-1 alpha coactivator program is amplified, the same pathway endurance exercise recruits
2. Mitochondrial biogenesis increases the cell’s oxidative capacity
3. Metabolism shifts toward fatty-acid oxidation, favouring fat as fuel
4. Whole-body energy expenditure rises while food intake stays unchanged in preclinical models

The net effect studied is a fat-mass reduction driven by burning more energy rather than eating less.

Reconstitution and Storage

Reconstitution: reconstitute the vial with bacteriostatic water (1 to 2ml); swirl gently until dissolved, do not shake. Keep capsules in a cool, dry place away from light. After reconstitution: hold refrigerated and use within 28 days.

For research purposes only. Not for human consumption.